Sadmir and his board game companions are just some of the 300 patients at the gaming disorder clinic, Australia's only ...
In recent months, Vor Biopharma closed a US$424.83 million shelf registration, repriced employee stock options, and reported positive late-stage clinical data for its autoimmune drug candidate ...
NEW YORK – TransCode Therapeutics' microRNA-10b inhibitor TTX-MC138 will be included in a Phase II branch of the PRE-I-SPY trial, the company announced Thursday.
We explore how longevity travel is redefining how we spend our free time and our choicee of destination for holidays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback